64 results
8-K
EX-10.3
ADAP
Adaptimmune Therapeutics plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
, improvement or innovation, whether or not patentable or capable of registration, and whether or not recorded in any medium.
page 10 of 13
You acknowledge
8-K
EX-10.4
ADAP
Adaptimmune Therapeutics plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
premises or resources).
"Invention" means any invention, idea, discovery, development, improvement or innovation, whether or not patentable or capable
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
or innovation, whether or not patentable or capable of registration, and whether or not recorded in any medium.
page 10 of 13
You acknowledge
424B3
ADAP
Adaptimmune Therapeutics plc
20 Apr 23
Prospectus supplement
4:32pm
company will be located in key innovation hubs and will have a deep bench of cell therapy professionals, infrastructure and end-to-end capabilities … will have greater expertise and technology access, which will allow Adaptimmune to accelerate innovation and sustain investment in rapid product
S-4/A
z4i5r2fe
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
4txyx6z6y9va 7q
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.2
zhim1 js6z9ibfwt0d
15 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
g8f8k
15 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.1
zoujwynjuh4mcq6qrx
15 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-99.1
t1wv35b8vzk85y02
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.1
3ryk0m 4kqqayf
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
eu4hlvtm
20 Aug 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-10.2
sx3ovgcn3
20 Aug 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-10.1
vwne fs2fvnm
20 Aug 21
Entry into a Material Definitive Agreement
4:31pm